![](/img/cover-not-exists.png)
Final results of a phase II study of bevacizumab plus docetaxel for the first-line treatment of metastatic breast cancer (TORI-B01)
S. Hurvitz, H.J. Allen, R.L. Moroose, D. Chan, C. Hagenstad, S.H. Applebaum, G. Patel, E.H. Hu, D.J. Slamon, F. KabbinavarVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70883-8
File:
PDF, 58 KB
english, 2008